Federated Hermes’s Wave Life Sciences WVE Stock Holding History

Federated Hermes’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.52M	Sell	1,466,234 -3,851,223	-72%	-$25.5M	0.01%	731
2026 Q1	$38.6M	Buy	5,317,457 +572,937	+12%	+$7.46M	0.06%	321
2025 Q4	$80.7M	Buy	4,744,520 +993,827	+26%	+$10.1M	0.13%	183
2025 Q3	$27.5M	Buy	3,750,693 +3,750,140	+678,145%	+$30.3M	0.05%	371
2025 Q2	$3.6K	Sell	553 -55,305	-99%	-$365K	﹤0.01%	1917
2025 Q1	$451K	Sell	55,858 -12,162	-18%	-$133K	﹤0.01%	1332
2024 Q4	$841K	Buy	+68,020	New	+$908K	﹤0.01%	1159
2024 Q2	–	Sell	-493	Closed	-$3.04K	–	2149
2024 Q1	$3.04K	Buy	493 +320	+185%	+$1.6K	﹤0.01%	1880
2023 Q4	$874	Sell	173 -141	-45%	-$754	﹤0.01%	1981
2023 Q3	$1.81K	Buy	+314	New	+$1.43K	﹤0.01%	1978
2022 Q2	–	Sell	-1,101	Closed	-$2K	–	2297
2022 Q1	$2K	Buy	+1,101	New	+$2.7K	﹤0.01%	2042

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Federated Hermes's WVE Position: Q2 2026 in Review

Federated Hermes reduced its Wave Life Sciences (WVE) stake by 72% in Q2 2026, selling an estimated $25.5M and leaving 1,466,234 shares worth $8.52M. The position accounts for 0.01% of the portfolio, ranked #731.

Federated Hermes first reported a position in WVE in Q1 2022 and has held it in 11 quarters since. The position peaked at $80.7M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Federated Hermes held 1,466,234 shares of Wave Life Sciences worth $8.52M as of Q2 2026.
Federated Hermes sold 3,851,223 Wave Life Sciences shares in Q2 2026, an estimated $25.5M.
Wave Life Sciences made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #731 holding.
Federated Hermes first reported a position in Wave Life Sciences in Q1 2022 and has held it in 11 quarters since.
Federated Hermes's Wave Life Sciences position peaked at $80.7M in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.